APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mefenamic Acid

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mefenamic Acid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchMefenamic Acid Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Mefenamic Acid Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Mefenamic Acid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mefenamic Acid Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Mefenamic Acid Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Mefenamic Acid market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mefenamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mefenamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mefenamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mefenamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mefenamic Acid include AA Pharma, ABL Lifecare, Adelco, Agron Remedies, Apotex, Captab, Chemidex Pharma, Daiichi Sankyo and EMS Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mefenamic Acid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mefenamic Acid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mefenamic Acid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mefenamic Acid market size, projected growth trends, production technologies, key applications, and end-use industries.

Mefenamic Acid Segment by Company

AA Pharma

ABL Lifecare

Adelco

Agron Remedies

Apotex

Captab

Chemidex Pharma

Daiichi Sankyo

EMS Pharma

Esteve

Farmo Quimica

IASIS Pharmaceuticals Hellas

Koa Isei

Mankind

Nisshin Pharmaceutical

Sanofi Aventis

Shinto Organics

Shionogi Pharma

Solitaire Pharmacia

Streuli Pharma,

Wockhardt

Yung Sine

Pfizer

Teva

Mefenamic Acid Segment by Type

Patent

Generic

Mefenamic Acid Segment by Application

On-line

Drug Store

Hospital

Mefenamic Acid Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mefenamic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mefenamic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mefenamic Acid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mefenamic Acid market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mefenamic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mefenamic Acid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mefenamic Acid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mefenamic Acid Industry Trends Table 2. Mefenamic Acid Industry Drivers Table 3. Mefenamic Acid Industry Opportunities and Challenges Table 4. Mefenamic Acid Industry Restraints Table 5. Global Mefenamic Acid Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mefenamic Acid Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mefenamic Acid Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Mefenamic Acid Sales Market Share by Manufacturers Table 9. Global Mefenamic Acid Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Mefenamic Acid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mefenamic Acid Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mefenamic Acid Manufacturers, Product Type & Application Table 13. Global Mefenamic Acid Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mefenamic Acid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Patent Table 17. Major Manufacturers of Generic Table 18. Global Mefenamic Acid Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 20. Global Mefenamic Acid Sales by Type (2027-2032) & (K Units) Table 21. Global Mefenamic Acid Sales Market Share by Type (2021-2026) Table 22. Global Mefenamic Acid Sales Market Share by Type (2027-2032) Table 23. Global Mefenamic Acid Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Mefenamic Acid Revenue by Type (2021-2026) & (K Units) Table 25. Global Mefenamic Acid Revenue by Type (2027-2032) & (K Units) Table 26. Global Mefenamic Acid Revenue Market Share by Type (2021-2026) Table 27. Global Mefenamic Acid Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of On-line Table 29. Major Manufacturers of Drug Store Table 30. Major Manufacturers of Hospital Table 31. Global Mefenamic Acid Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 33. Global Mefenamic Acid Sales by Application (2027-2032) & (K Units) Table 34. Global Mefenamic Acid Sales Market Share by Application (2021-2026) Table 35. Global Mefenamic Acid Sales Market Share by Application (2027-2032) Table 36. Global Mefenamic Acid Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Mefenamic Acid Revenue by Application (2021-2026) & (K Units) Table 38. Global Mefenamic Acid Revenue by Application (2027-2032) & (K Units) Table 39. Global Mefenamic Acid Revenue Market Share by Application (2021-2026) Table 40. Global Mefenamic Acid Revenue Market Share by Application (2027-2032) Table 41. Global Mefenamic Acid Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Mefenamic Acid Sales by Region (2021-2026) & (K Units) Table 43. Global Mefenamic Acid Sales Market Share by Region (2021-2026) Table 44. Global Mefenamic Acid Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Mefenamic Acid Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Mefenamic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 48. North America Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 49. Europe Mefenamic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 51. Europe Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Mefenamic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Mefenamic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 58. Global Mefenamic Acid Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Mefenamic Acid Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Mefenamic Acid Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Mefenamic Acid Revenue Market Share by Region (2021-2026) Table 62. Global Mefenamic Acid Revenue Market Share by Region (2027-2032) Table 63. AA Pharma Company Information Table 64. AA Pharma Business Overview Table 65. AA Pharma Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. AA Pharma Mefenamic Acid Product Portfolio Table 67. AA Pharma Recent Development Table 68. ABL Lifecare Company Information Table 69. ABL Lifecare Business Overview Table 70. ABL Lifecare Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. ABL Lifecare Mefenamic Acid Product Portfolio Table 72. ABL Lifecare Recent Development Table 73. Adelco Company Information Table 74. Adelco Business Overview Table 75. Adelco Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Adelco Mefenamic Acid Product Portfolio Table 77. Adelco Recent Development Table 78. Agron Remedies Company Information Table 79. Agron Remedies Business Overview Table 80. Agron Remedies Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Agron Remedies Mefenamic Acid Product Portfolio Table 82. Agron Remedies Recent Development Table 83. Apotex Company Information Table 84. Apotex Business Overview Table 85. Apotex Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Apotex Mefenamic Acid Product Portfolio Table 87. Apotex Recent Development Table 88. Captab Company Information Table 89. Captab Business Overview Table 90. Captab Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Captab Mefenamic Acid Product Portfolio Table 92. Captab Recent Development Table 93. Chemidex Pharma Company Information Table 94. Chemidex Pharma Business Overview Table 95. Chemidex Pharma Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Chemidex Pharma Mefenamic Acid Product Portfolio Table 97. Chemidex Pharma Recent Development Table 98. Daiichi Sankyo Company Information Table 99. Daiichi Sankyo Business Overview Table 100. Daiichi Sankyo Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Daiichi Sankyo Mefenamic Acid Product Portfolio Table 102. Daiichi Sankyo Recent Development Table 103. EMS Pharma Company Information Table 104. EMS Pharma Business Overview Table 105. EMS Pharma Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. EMS Pharma Mefenamic Acid Product Portfolio Table 107. EMS Pharma Recent Development Table 108. Esteve Company Information Table 109. Esteve Business Overview Table 110. Esteve Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Esteve Mefenamic Acid Product Portfolio Table 112. Esteve Recent Development Table 113. Farmo Quimica Company Information Table 114. Farmo Quimica Business Overview Table 115. Farmo Quimica Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Farmo Quimica Mefenamic Acid Product Portfolio Table 117. Farmo Quimica Recent Development Table 118. IASIS Pharmaceuticals Hellas Company Information Table 119. IASIS Pharmaceuticals Hellas Business Overview Table 120. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio Table 122. IASIS Pharmaceuticals Hellas Recent Development Table 123. Koa Isei Company Information Table 124. Koa Isei Business Overview Table 125. Koa Isei Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Koa Isei Mefenamic Acid Product Portfolio Table 127. Koa Isei Recent Development Table 128. Mankind Company Information Table 129. Mankind Business Overview Table 130. Mankind Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Mankind Mefenamic Acid Product Portfolio Table 132. Mankind Recent Development Table 133. Nisshin Pharmaceutical Company Information Table 134. Nisshin Pharmaceutical Business Overview Table 135. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Nisshin Pharmaceutical Mefenamic Acid Product Portfolio Table 137. Nisshin Pharmaceutical Recent Development Table 138. Sanofi Aventis Company Information Table 139. Sanofi Aventis Business Overview Table 140. Sanofi Aventis Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Sanofi Aventis Mefenamic Acid Product Portfolio Table 142. Sanofi Aventis Recent Development Table 143. Shinto Organics Company Information Table 144. Shinto Organics Business Overview Table 145. Shinto Organics Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Shinto Organics Mefenamic Acid Product Portfolio Table 147. Shinto Organics Recent Development Table 148. Shionogi Pharma Company Information Table 149. Shionogi Pharma Business Overview Table 150. Shionogi Pharma Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Shionogi Pharma Mefenamic Acid Product Portfolio Table 152. Shionogi Pharma Recent Development Table 153. Solitaire Pharmacia Company Information Table 154. Solitaire Pharmacia Business Overview Table 155. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Solitaire Pharmacia Mefenamic Acid Product Portfolio Table 157. Solitaire Pharmacia Recent Development Table 158. Streuli Pharma, Company Information Table 159. Streuli Pharma, Business Overview Table 160. Streuli Pharma, Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Streuli Pharma, Mefenamic Acid Product Portfolio Table 162. Streuli Pharma, Recent Development Table 163. Wockhardt Company Information Table 164. Wockhardt Business Overview Table 165. Wockhardt Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Wockhardt Mefenamic Acid Product Portfolio Table 167. Wockhardt Recent Development Table 168. Yung Sine Company Information Table 169. Yung Sine Business Overview Table 170. Yung Sine Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Yung Sine Mefenamic Acid Product Portfolio Table 172. Yung Sine Recent Development Table 173. Pfizer Company Information Table 174. Pfizer Business Overview Table 175. Pfizer Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Pfizer Mefenamic Acid Product Portfolio Table 177. Pfizer Recent Development Table 178. Teva Company Information Table 179. Teva Business Overview Table 180. Teva Mefenamic Acid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 181. Teva Mefenamic Acid Product Portfolio Table 182. Teva Recent Development Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Mefenamic Acid Distributors List Table 186. Mefenamic Acid Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Mefenamic Acid Product Image Figure 2. Global Mefenamic Acid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mefenamic Acid Market Size (2021-2032) & (US$ Million) Figure 4. Global Mefenamic Acid Sales (2021-2032) & (K Units) Figure 5. Global Mefenamic Acid Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Mefenamic Acid Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Patent Image Figure 9. Generic Image Figure 10. Global Mefenamic Acid Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Mefenamic Acid Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Mefenamic Acid Sales Market Share by Type (2021-2032) Figure 13. Global Mefenamic Acid Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Mefenamic Acid Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Mefenamic Acid Revenue Market Share by Type (2021-2032) Figure 16. On-line Image Figure 17. Drug Store Image Figure 18. Hospital Image Figure 19. Global Mefenamic Acid Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Mefenamic Acid Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Mefenamic Acid Sales Market Share by Application (2021-2032) Figure 22. Global Mefenamic Acid Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Mefenamic Acid Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Mefenamic Acid Revenue Market Share by Application (2021-2032) Figure 25. North America Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Mefenamic Acid Sales Market Share by Country (2021-2032) Figure 27. U.S. Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Mefenamic Acid Sales Market Share by Country (2021-2032) Figure 32. Germany Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Mefenamic Acid Sales Market Share by Country (2021-2032) Figure 39. China Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Mefenamic Acid Sales Market Share by Country (2021-2032) Figure 47. Brazil Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Mefenamic Acid Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Mefenamic Acid Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Mefenamic Acid Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Mefenamic Acid Revenue (2021-2032) & (US$ Million) Figure 58. North America Mefenamic Acid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Mefenamic Acid Revenue (2021-2032) & (US$ Million) Figure 60. Europe Mefenamic Acid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Mefenamic Acid Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Mefenamic Acid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Mefenamic Acid Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Mefenamic Acid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Mefenamic Acid Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Mefenamic Acid Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • On-line
  • Drug Store
  • Hospital
Companies covered
  • AA Pharma
  • ABL Lifecare
  • Adelco
  • Agron Remedies
  • Apotex
  • Captab
  • Chemidex Pharma
  • Daiichi Sankyo
  • EMS Pharma
  • Esteve
  • Farmo Quimica
  • IASIS Pharmaceuticals Hellas
  • Koa Isei
  • Mankind
  • Nisshin Pharmaceutical
  • Sanofi Aventis
  • Shinto Organics
  • Shionogi Pharma
  • Solitaire Pharmacia
  • Streuli Pharma,
  • Wockhardt
  • Yung Sine
  • Pfizer
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mefenamic Acid Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mefenamic Acid Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mefenamic Acid Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mefenamic Acid Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mefenamic Acid Market Dynamics
  1. 2.1 Mefenamic Acid Industry Trends
  2. 2.2 Mefenamic Acid Industry Drivers
  3. 2.3 Mefenamic Acid Industry Opportunities and Challenges
  4. 2.4 Mefenamic Acid Industry Restraints
3 Mefenamic Acid Market by Manufacturers
  1. 3.1 Global Mefenamic Acid Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mefenamic Acid Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mefenamic Acid Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mefenamic Acid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mefenamic Acid Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mefenamic Acid Manufacturers, Product Type & Application
  7. 3.7 Global Mefenamic Acid Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mefenamic Acid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mefenamic Acid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mefenamic Acid Tier 1, Tier 2, and Tier 3
4 Mefenamic Acid Market by Type
  1. 4.1 Mefenamic Acid Type Introduction
  2. 4.1.1 Patent
  3. 4.1.2 Generic
  4. 4.2 Global Mefenamic Acid Sales by Type
  5. 4.2.1 Global Mefenamic Acid Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mefenamic Acid Sales by Type (2021-2032)
  7. 4.2.3 Global Mefenamic Acid Sales Market Share by Type (2021-2032)
  8. 4.3 Global Mefenamic Acid Revenue by Type
  9. 4.3.1 Global Mefenamic Acid Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Mefenamic Acid Revenue by Type (2021-2032)
  11. 4.3.3 Global Mefenamic Acid Revenue Market Share by Type (2021-2032)
5 Mefenamic Acid Market by Application
  1. 5.1 Mefenamic Acid Application Introduction
  2. 5.1.1 On-line
  3. 5.1.2 Drug Store
  4. 5.1.3 Hospital
  5. 5.2 Global Mefenamic Acid Sales by Application
  6. 5.2.1 Global Mefenamic Acid Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mefenamic Acid Sales by Application (2021-2032)
  8. 5.2.3 Global Mefenamic Acid Sales Market Share by Application (2021-2032)
  9. 5.3 Global Mefenamic Acid Revenue by Application
  10. 5.3.1 Global Mefenamic Acid Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mefenamic Acid Revenue by Application (2021-2032)
  12. 5.3.3 Global Mefenamic Acid Revenue Market Share by Application (2021-2032)
6 Global Mefenamic Acid Sales by Region
  1. 6.1 Global Mefenamic Acid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mefenamic Acid Sales by Region (2021-2032)
  3. 6.2.1 Global Mefenamic Acid Sales by Region (2021-2026)
  4. 6.2.2 Global Mefenamic Acid Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mefenamic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mefenamic Acid Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mefenamic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mefenamic Acid Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mefenamic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mefenamic Acid Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mefenamic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mefenamic Acid Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mefenamic Acid Revenue by Region
  1. 7.1 Global Mefenamic Acid Revenue by Region
  2. 7.1.1 Global Mefenamic Acid Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mefenamic Acid Revenue by Region (2021-2026)
  4. 7.1.3 Global Mefenamic Acid Revenue by Region (2027-2032)
  5. 7.1.4 Global Mefenamic Acid Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mefenamic Acid Revenue (2021-2032)
  8. 7.2.2 North America Mefenamic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mefenamic Acid Revenue (2021-2032)
  11. 7.3.2 Europe Mefenamic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mefenamic Acid Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mefenamic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mefenamic Acid Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mefenamic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AA Pharma
  2. 8.1.1 AA Pharma Company Information
  3. 8.1.2 AA Pharma Business Overview
  4. 8.1.3 AA Pharma Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AA Pharma Mefenamic Acid Product Portfolio
  6. 8.1.5 AA Pharma Recent Developments
  7. 8.2 ABL Lifecare
  8. 8.2.1 ABL Lifecare Company Information
  9. 8.2.2 ABL Lifecare Business Overview
  10. 8.2.3 ABL Lifecare Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ABL Lifecare Mefenamic Acid Product Portfolio
  12. 8.2.5 ABL Lifecare Recent Developments
  13. 8.3 Adelco
  14. 8.3.1 Adelco Company Information
  15. 8.3.2 Adelco Business Overview
  16. 8.3.3 Adelco Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Adelco Mefenamic Acid Product Portfolio
  18. 8.3.5 Adelco Recent Developments
  19. 8.4 Agron Remedies
  20. 8.4.1 Agron Remedies Company Information
  21. 8.4.2 Agron Remedies Business Overview
  22. 8.4.3 Agron Remedies Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Agron Remedies Mefenamic Acid Product Portfolio
  24. 8.4.5 Agron Remedies Recent Developments
  25. 8.5 Apotex
  26. 8.5.1 Apotex Company Information
  27. 8.5.2 Apotex Business Overview
  28. 8.5.3 Apotex Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Apotex Mefenamic Acid Product Portfolio
  30. 8.5.5 Apotex Recent Developments
  31. 8.6 Captab
  32. 8.6.1 Captab Company Information
  33. 8.6.2 Captab Business Overview
  34. 8.6.3 Captab Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Captab Mefenamic Acid Product Portfolio
  36. 8.6.5 Captab Recent Developments
  37. 8.7 Chemidex Pharma
  38. 8.7.1 Chemidex Pharma Company Information
  39. 8.7.2 Chemidex Pharma Business Overview
  40. 8.7.3 Chemidex Pharma Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Chemidex Pharma Mefenamic Acid Product Portfolio
  42. 8.7.5 Chemidex Pharma Recent Developments
  43. 8.8 Daiichi Sankyo
  44. 8.8.1 Daiichi Sankyo Company Information
  45. 8.8.2 Daiichi Sankyo Business Overview
  46. 8.8.3 Daiichi Sankyo Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Daiichi Sankyo Mefenamic Acid Product Portfolio
  48. 8.8.5 Daiichi Sankyo Recent Developments
  49. 8.9 EMS Pharma
  50. 8.9.1 EMS Pharma Company Information
  51. 8.9.2 EMS Pharma Business Overview
  52. 8.9.3 EMS Pharma Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EMS Pharma Mefenamic Acid Product Portfolio
  54. 8.9.5 EMS Pharma Recent Developments
  55. 8.10 Esteve
  56. 8.10.1 Esteve Company Information
  57. 8.10.2 Esteve Business Overview
  58. 8.10.3 Esteve Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Esteve Mefenamic Acid Product Portfolio
  60. 8.10.5 Esteve Recent Developments
  61. 8.11 Farmo Quimica
  62. 8.11.1 Farmo Quimica Company Information
  63. 8.11.2 Farmo Quimica Business Overview
  64. 8.11.3 Farmo Quimica Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Farmo Quimica Mefenamic Acid Product Portfolio
  66. 8.11.5 Farmo Quimica Recent Developments
  67. 8.12 IASIS Pharmaceuticals Hellas
  68. 8.12.1 IASIS Pharmaceuticals Hellas Company Information
  69. 8.12.2 IASIS Pharmaceuticals Hellas Business Overview
  70. 8.12.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio
  72. 8.12.5 IASIS Pharmaceuticals Hellas Recent Developments
  73. 8.13 Koa Isei
  74. 8.13.1 Koa Isei Company Information
  75. 8.13.2 Koa Isei Business Overview
  76. 8.13.3 Koa Isei Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Koa Isei Mefenamic Acid Product Portfolio
  78. 8.13.5 Koa Isei Recent Developments
  79. 8.14 Mankind
  80. 8.14.1 Mankind Company Information
  81. 8.14.2 Mankind Business Overview
  82. 8.14.3 Mankind Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Mankind Mefenamic Acid Product Portfolio
  84. 8.14.5 Mankind Recent Developments
  85. 8.15 Nisshin Pharmaceutical
  86. 8.15.1 Nisshin Pharmaceutical Company Information
  87. 8.15.2 Nisshin Pharmaceutical Business Overview
  88. 8.15.3 Nisshin Pharmaceutical Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nisshin Pharmaceutical Mefenamic Acid Product Portfolio
  90. 8.15.5 Nisshin Pharmaceutical Recent Developments
  91. 8.16 Sanofi Aventis
  92. 8.16.1 Sanofi Aventis Company Information
  93. 8.16.2 Sanofi Aventis Business Overview
  94. 8.16.3 Sanofi Aventis Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sanofi Aventis Mefenamic Acid Product Portfolio
  96. 8.16.5 Sanofi Aventis Recent Developments
  97. 8.17 Shinto Organics
  98. 8.17.1 Shinto Organics Company Information
  99. 8.17.2 Shinto Organics Business Overview
  100. 8.17.3 Shinto Organics Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Shinto Organics Mefenamic Acid Product Portfolio
  102. 8.17.5 Shinto Organics Recent Developments
  103. 8.18 Shionogi Pharma
  104. 8.18.1 Shionogi Pharma Company Information
  105. 8.18.2 Shionogi Pharma Business Overview
  106. 8.18.3 Shionogi Pharma Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Shionogi Pharma Mefenamic Acid Product Portfolio
  108. 8.18.5 Shionogi Pharma Recent Developments
  109. 8.19 Solitaire Pharmacia
  110. 8.19.1 Solitaire Pharmacia Company Information
  111. 8.19.2 Solitaire Pharmacia Business Overview
  112. 8.19.3 Solitaire Pharmacia Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Solitaire Pharmacia Mefenamic Acid Product Portfolio
  114. 8.19.5 Solitaire Pharmacia Recent Developments
  115. 8.20 Streuli Pharma,
  116. 8.20.1 Streuli Pharma, Company Information
  117. 8.20.2 Streuli Pharma, Business Overview
  118. 8.20.3 Streuli Pharma, Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Streuli Pharma, Mefenamic Acid Product Portfolio
  120. 8.20.5 Streuli Pharma, Recent Developments
  121. 8.21 Wockhardt
  122. 8.21.1 Wockhardt Company Information
  123. 8.21.2 Wockhardt Business Overview
  124. 8.21.3 Wockhardt Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Wockhardt Mefenamic Acid Product Portfolio
  126. 8.21.5 Wockhardt Recent Developments
  127. 8.22 Yung Sine
  128. 8.22.1 Yung Sine Company Information
  129. 8.22.2 Yung Sine Business Overview
  130. 8.22.3 Yung Sine Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Yung Sine Mefenamic Acid Product Portfolio
  132. 8.22.5 Yung Sine Recent Developments
  133. 8.23 Pfizer
  134. 8.23.1 Pfizer Company Information
  135. 8.23.2 Pfizer Business Overview
  136. 8.23.3 Pfizer Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Pfizer Mefenamic Acid Product Portfolio
  138. 8.23.5 Pfizer Recent Developments
  139. 8.24 Teva
  140. 8.24.1 Teva Company Information
  141. 8.24.2 Teva Business Overview
  142. 8.24.3 Teva Mefenamic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Teva Mefenamic Acid Product Portfolio
  144. 8.24.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mefenamic Acid Value Chain Analysis
  2. 9.1.1 Mefenamic Acid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mefenamic Acid Production Mode & Process
  6. 9.2 Mefenamic Acid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mefenamic Acid Distributors
  9. 9.2.3 Mefenamic Acid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst